COVID-19 Sample Collection Kits; Accurate and Reliable Test for Diagnosing COVID-19

 

COVID-19 Sample Collection Kits Market
COVID-19 Sample Collection Kits

The COVID-19 sample collection kits are used to diagnose and detect COVID-19, an infectious disease caused by the SARS-CoV-2 virus. It is the most critical step in the effective diagnosis of active infection. COVID-19 sample collection kits comprises the critical reagents provided for collecting the samples and delivering them to the laboratory to diagnose and detect SARS-CoV2 virus infection. Different types of kits are available to diagnose COVID-19, such as swab collection kit for RT-PCR test and rapid antigen test.

The swabs are available in various packaging formats, from bulk packs ideal for diagnostic kit assembly, to single swab peel-packs ideal for POC (Point of Care) testing. The contents of this kit are to be used for the qualitative detection of SARS-CoV-2 antigen from nasal swab. Other specimen types may lead to incorrect results and must not be used. The nose swab PCR test for COVID-19 is an accurate and reliable test for diagnosing COVID-19. Get tested if you have symptoms of COVID-19 or have been exposed to someone who tested positive.

The Global COVID-19 Sample Collection Kits Market is estimated to be valued at US$ 12.0 billion in 2021 and expected to exhibit a CAGR of 4.1% during the forecast period (2021-2028).

Rapid diagnostic test (RDT) of a sample of the respiratory tract of a person helps to detect the viral proteins (antigens) related to COVID-19. Along with laboratory tests, chest CT scans may be helpful to diagnose COVID-19 infection. Thus, with the increase in number of COVID-19 cases, the demand for COVID-19 sample collection kits is also increasing. According to the World Health Organization (WHO), there have been 81,824,843 confirmed cases of COVID-19 in the U.S., from 3 January 2020 to 18 May 2022, with 992,667 deaths.

Since the start of the pandemic, the Food and Drug Administration (FDA) has authorized more than 400 tests and collection kits, including 235 molecular tests, 88 antibody tests, & 34 antigen tests. The FDA is committed to helping ensure the public has access to a wide variety of test options for COVID-19.

Comments

Popular posts from this blog

Rising lymphocytic leukemia to augment Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market Growth

Health Caregiving; used to help in daily activities

Rising Technological Developments To Boost Ultrasonic Non-Destructive Testing (NDT) Equipment Market Growth